February 14, 2024

Global Brain has invested in michibiku, Inc., a corporate governance technology company offering a Japanese Companies Act-based board portal "michibiku," as the lead investor

Global Brain has invested in michibiku, Inc. (michibiku), a corporate governance technology company offering a Japanese Companies Act-based board portal "michibiku," through its FUKOKU -THE MUTUAL for Next 100 Fund L.P. (TMN100) and Norinchukin Innovation Fund L.P. (NCIF) as the lead investor.

Even with the recent progress of digital transformation (DX) in all industries and operations, analog approach to management and administrative operations still persists in the area of corporate governance. michibiku has developed a product that significantly reduces the burden on both the board members and secretariat and enables sophisticated decision-making. The company plans to release a wide variety of DX products related to corporate governance in the future by proactively responding to the potential needs of client companies and various regulatory reforms.

Global Brain has decided to invest in michibiku as the lead investor in this round, highly recognizing CEO Nakamura and the management team’s ability to deeply understand the issues faced by the board members and secretariat, the product that is winning client companies, and the potential of this area and the company. Global Brain will actively support michibiku so that it can become a leading corporate governance technology company in the near future.

About michibiku

Location
Shibuya-ku, Tokyo, Japan
Representative
Tatsunori Nakamura
Founded
April 2021
URL
https://michibiku.co.jp/
(Available only in Japanese)

About TMN100

Name
FUKOKU -THE MUTUAL for Next 100 Fund L.P.
General Partner
Global Brain Corporation

About NCIF

Name
Norinchukin Innovation Fund L.P.
General Partner
Global Brain Corporation

About Global Brain

Location
Tokyo, Japan
Representative
Yasuhiko Yurimoto
Founded
January 1998
URL
https://globalbrains.com/

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.